Example: Heart Attack

Search clinical trials for: Abacavir

Total 236 results

NCT01886638

Completed

Determining the Effect of Abacavir on Platelet Activation

Conditions: HIV; Cardiovascular Disease
NCT01153217

Completed

Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density

Conditions: HIV
NCT01973439

Completed

PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months

Conditions: HIV Infection
NCT01205243

Completed

ZIAGEN® Post-marketing Surveillance

Conditions: Infection, Human Immunodeficiency Virus I
NCT02093585

Completed

Tenofovir Abacavir Platelet Activation Study

Conditions: HIV
NCT01656122

Completed

Abacavir and Lamivudine PK in Children

Conditions: HIV
NCT02101216

Completed

Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers

Conditions: Psoriasis
NCT02957864

Recruiting

Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide

Conditions: Renal Insufficiency,Chronic; Hiv; Therapeutic Agent Toxicity
NCT02659761

Unknown status

Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs

Conditions: Human Immunodeficiency Virus
NCT01052701

Completed

Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment

Conditions: Hepatitis C; HIV
NCT00214890

Completed

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

Conditions: HIV Infections
NCT02067767

Completed

Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)

Conditions: HIV-1 Infection
NCT00340080

Completed

Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity

Conditions: HIV Infection
NCT00320307

Completed

Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects

Conditions: HIV Infection
NCT01220232

Completed

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Conditions: Healthy Volunteers
NCT02509195

Completed

SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over

Conditions: HIV
NCT01900106

Completed

A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)

Conditions: HIV Infection
NCT00011479

Completed

Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

Conditions: HIV Infections
NCT00765271

Completed

Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects

Conditions: HIV
NCT01059422

Unknown status

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Conditions: HIV Infections; Tuberculosis
NCT00046176

Completed

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Conditions: Infection, Human Immunodeficiency Virus I; HIV Infection
NCT00740064

Unknown status

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

Conditions: HIV Infections
NCT00314626

Completed

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily

Conditions: HIV Infections
NCT01366547

Completed

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Conditions: Healthy Subjects; Infection, Human Immunodeficiency Virus
NCT00647244

Completed

Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients

Conditions: HIV Infections